The use of oral contraceptives (OC) is a well established risk factor for venous thrombosis. It
has been known for many years that almost all haemostatic parameters ie plasma levels of …

Although venous thrombosis has been traditionally associated with stasis and
hypercoagulability, arterial thrombosis is mainly associated with heightened platelet …

Pregnant women show a low level of protein S (PS) in plasma, which is known to be a risk
for deep venous thrombosis. 17β-Estradiol (E 2), an estrogen that increases in concentration …

Hormonal contraceptives are a popular method of contraception, but their use has been
associated with an increased risk for venous thromboembolism. In order to reduce such risk …

The aim of this review is to define the role of the combined dienogest (DNG)/estradiol
valerate (E2V) contraceptive pill, in terms of biochemistry, metabolic and pharmacological …

Conflicting data have been reported on the accuracy of protein S (PS) assays for detection of
hereditary PS deficiency. In this study we assessed the diagnostic performance of two total …

Page 1 Langzyklus weniger Menstruationen - weniger Menstruationsbeschwerden – weniger
zyklusabhängige Erkrankungen Inka Wiegratz Herbert Kuhl Л Langzyklus Standardzyklus 1 2 …

Das thromboembolische Risiko unter kombinierten hormonalen Kontrazeptiva (CHC) wurde
in den letzten 35 Jahren durch die Entwicklung niedrigdosierter CHC (nCHC)(≤ 35 µg …

Oral contraceptives and adverse effects In 1959 the first contraceptive pill composed of 9.85
mg norethynodrel and 150 g mesa tranol (Enovid, GD Searle&Co., Chicago, USA) was …

Not only venous thromboembolic events but also the sum of all side effects are decisive for
the prescription of oral contraceptives. Based on the data available today, the following …